Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
33%
Ph not_applicable
3
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(1)
Other(1)

Detailed Status

Recruiting2
unknown1
Completed1
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (40.0%)
N/A3 (60.0%)

Trials by Status

unknown117%
recruiting233%
completed117%
enrolling_by_invitation117%
not_yet_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6